• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×
  • 06 Mar 17
title

CFD platforms still worth a look

  • 3449 views
The Naked Fund Manager

UK-focused Small and Mid-cap fund manager.

 
CFD platforms
Strap line

PE multiples have partially converged but range is still wide. FCA consultation ends tomorrow.

Companies: CMCX, IGG, PLUS


Body

 

Afternoon all,


Back to school, and yet another strong week for equity markets. Thanks to Rob for filling in for me with his excellent piece on Purplebricks.


I thought I would revisit the CFD platforms this week. I wrote about them in one of my earlier blogs last year, and a lot has happened since then. They’ve all performed very nicely, and PLUS has been on a tear, although it was starting from such a low base this should not have been a surprise. As mentioned before, I am a holder of these companies.


 

Massive PLUS dividend last week - Be careful of the tax!

Before reviewing the lie of the land for the CFD platforms, I want to point out the giant Plus 500 dividend that went "ex" last week. The critical detail I want to highlight to all readers who hold shares, as we do, is that you will be charged 25% tax on your dividend unless you apply to the Israel Tax Authority (ITA) and obtain a certificate for a reduced withholding tax rate of 15%. The shares went ex-dividend on the 2nd March.


Here’s the form from the ITA: https://taxes.gov.il/English/TaxesFormsList/itca114.pdf


For more detail on the Israeli withholding tax process, there is a useful article here from 2014:


 

PLUS has outperformed CMC and IGG since drop

All three CFD providers have been good performers since the original slide in share prices following the announcements from the FCA and other regulators in early December. However, PLUS has been the standout performer of the three with a 29% rise in share price, versus 9%/10% for the other two.


CFD platforms IGG PLUS and CMCX share price performance since FCA bombshell

I would just point out that I’ve incorporated the 53p dividend from PLUS that went ex last week (after stripping 15% withholding tax from the gross amount). Even net of tax, that still equated to a lovely c.10% dividend yield. I would not expect this level of special dividends (22p of the 53p) to continue now there is significant regulatory uncertainty.


 

How did the Brokers react

Consensus forecasts for all three CFD platforms took a hammering after the regulatory announcements with a moderate hit to 2017 earnings and a bigger hit in 2018, which will be the first full year to be affected by any changes that may be coming.


Below is a chart showing consensus EPS forecasts for 2018 and how they changed post the FCA announcement.


EPS forecast changes for IG, PLUS and CMC Markets post FCA consultation

As you can see, analysts were far more aggressive in their cuts to forecasts for CMC and PLUS, whose numbers came down 44% and 40% respectively, than they were for IG, whose 2018 consensus EPS estimates reduced 23%.


Part of this could be a perception that IG is the market leader, certainly in the UK, and it operates further up the quality chain than PLUS. This is probably fair.

 

However, another factor which I think we could be seeing here is the difference in coverage depth. PLUS and CMC both have fewer analysts covering them than c.£2bn market cap IG Group. Therefore consensus will have more of a weighting from the corporate brokers. These analysts may well err more on the side of conservatism in the face of an uncertain conclusion to the consultation period. Analysts much prefer to increase forecasts into good news and a recovery.


 

Finally what multiples has the market been discounting

I looked at the 2018 price-to-earnings multiple the market has been applying to each of the CFD platforms and how that has evolved over time, starting about a week before the regulatory bombshells hit.

 

PE evolution for PLUS IGG and CMCX before and during FCA consultation period 2016 2017

Interesting conclusions to be drawn from the above chart:

 

  • There was a severe differential in the multiple the market was willing to give each CFD player before the regulatory bombshell. IGG was the premium stock trading at around 16x 2018 earnings. CMC was only given a 10x rating which is mainly due to previous recent profit warnings. Plus 500 was the lowest rated by the market at a lowly 7x 2018 forecast earnings, primarily due to the significant issues it had already faced with the FCA.
  • After the regulatory announcements, IG’s valuation took a knock dropping to 11x before climbing to 13x today. The CMC multiple barely moved. Plus 500 briefly fell as low as 6x earnings but has since rallied strongly to 9.4x today.

Overall there has been a converging of multiples. However, there is still a sizeable c.40% gap between the valuation placed on IG shares and that placed on PLUS shares. Furthermore, the multiples are based on Plus 500’s consensus earnings forecasts that were slashed 40%, compared to IG’s falling 23%.


 

Cash on the Balance Sheet should be accounted for

My analysis of P/E multiples above doesn’t account for the amount of cash on the Balance Sheets, which is a further reason why I like these companies.


IG Group and PLUS are both generating lots of cash but are also sitting on large cash balances, CMC slightly less so. It is important to strip out client cash which all three do clearly in their Financial Statements. After removing client funds from the equation, IG is sitting on a cash pile of c.£220m (July 2016 Results), CMC has £42m, and PLUS had an enormous $136m at year end. When compared to the market caps of £2bn for IG, £350m for CMC and £490m for PLUS, that’s a lot of excess cash.


Analysis of the earnings multiple discounted by the market should strip out this excess cash first, which would put the three on even lower multiples.


 

Consultation period to close tomorrow - what next?

The FCA’s consultation period runs until the 7th March, i.e., tomorrow. All comments must be submitted before the deadline, and then the Policy Statement is scheduled to be released in “Spring 2017”. This gives the FCA until mid-June 2017 to digest the various views of key players and come to a decision.


As highlighted by a number of analysts, there is a real risk of regulatory arbitrage should the FCA and the other regulators (e.g., BaFin) decide upon very different measures. I would expect the FCA’s decision to take the actions of the other regulators into account.


The only real catalyst that matters over the coming months is the decisions of the various regulators, particularly the FCA and BaFin. Any move by the FCA towards the other regulators’ position of a preference for limited risk accounts rather than onerous leverage caps would be a significant positive for all CFD platforms.

 

 

-----

 

To read a brief outline of how I think about stocks, and what I aim to achieve in this blog, please check out my first blog where I set out my stall.

 

Recent blogs:

  • 27 Feb 17 - Purplebricks US expansion: How big is the opportunity?
  • 20 Feb 17 - M&A - One reason why I’m still bullish on UK equities
  • 14 Feb 17 - Anatomy of a growth company
  • 6 Feb 17 - Roll-outs: the Good, the Bad and the Ugly
  • 30 Jan 17 - How MiFID II could hurt Small and Mid-caps
  • 23 Jan 17 - Why Pearson was an obvious value trap, and is Jackpotjoy worth a closer look?
  • 16 Jan 17 - How sustainable are current dividends
  • 8 Jan 17 - Implications of Trumponomics for equities
  • 18 Dec 16 - Millennials - Becoming the most important demographic
  • 12 Dec 16 - CFDs - Tough week but worth a closer look
  • 5 Dec 16 - Pension deficit dogs starting to look interesting
  • 28 Nov 16 - Setting out my stall...plus my thoughts on bond proxies 

Please Note: To be clear, I do not and will not ever give any advice. I will rarely mention individual stocks but when I do these will not be recommendations, instead just my thoughts at that point in time.

 


Body Two

Body Three

Body Four

Body Five

The information contained within this post is based on personal experience and opinion and should not be considered as a recommendation to trade nor financial advice.

More Content

More Content

Cryptocurrencies 12 May 2025

Companies: ALNEV IOTC BTSC BTGN NMOC NLTX NMRD NEOD NEO NBCO NEOL NEOG NEN NMT SRZ NEO 1868 NEOE3 ADE NPTN UUSA PNG NNE NEO NVC NEM NBM BTCW KLH SPX NEM NEON NMGC NEOLA NEO NGL NEOM NMX BNDI NEOS MLNLF NELR ALNLF NCI NEM 6922 NEO STEL TLTI NEO PLUS NEOGEN NEOL STCS NGI NEO NSP NTX 950220 3921 NEOH 042420 085910 092730 094860 095660 212560 253590 290660 306620 311390 8167 NEON QBTC NTMC NEOFI NPFL NLC NGRD3 NDT NEOG NEMYSIS NEM 172A BTCI NMGC NEOBO IWMI 4196 SVCCU IYRI COINXBT NTHI HYBI ZVNS 4131 SPYI ALNEV BTGN STEL QQQH NBCO NEOM NTGN NEOV BTM NMRD NEOB CSHI CASL NEMAKA QQQI SPYH

Acquisdata

6 great dividend-paying stocks for your 2016/17 ISA or SIPP

Companies: BWYPSNMKSKGFPAYIGGPLUS

Research Tree

PANMURE LIBERUM: Plus500: Valuation bump

Companies: Plus500 Ltd.

Panmure Liberum

8 of the best performing AIM-listed stocks of 2017 (so far)

Companies: IQEWEYFEVRJOGPURPPLUSHCMNEXN

Research Tree

PANMURE LIBERUM: Leveraged trading platforms: Reflecting the pivot to higher quality workstreams

Companies: IGG CMCX PLUS

Panmure Liberum
next
 
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • Chrome Extension
  • iOS and Android Apps
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2025

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Acquisdata
      • Actinver
      • Actio Advisors
      • Asset TV
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Brand Communications
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Edge Group
      • The Life Sciences Division
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Align Research
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • Allenby Capital
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In